Sector: Pharmaceuticals & Biotechnology

Mid Cap

Viyash Scientific Share Price

Viyash Scientific Ltd.

₹262.94

1.98(0.76%)

Invest in SEQUENT with up to 2.22x margin.

Trade with MTF

No Graph

NSE : VIYASH

Open Free Demat Account

Viyash Scientific Performance

Price Movement

N/A

₹255.85

₹264.70

↘ Today's Low↗ Today's High

1 Year Performance

N/A

₹166.00

₹268.70

↘ 52 Week Low↗ 52 Week High

Markets Today

High₹264.70

Low₹255.85

Open at₹262.94

Prev Close₹260.96

Volumes12.82 L

Avg Price₹259.39

Lower Circuit₹208.77

Upper Circuit₹313.15

Historical Performance

3M High₹268.70

3M Low₹178.13

1 Yr High₹268.70

1 Yr Low₹166.00

3 Yr High₹268.70

3 Yr Low₹71.80

5 Yr High₹336.50

5 Yr Low₹61.80

Viyash Scientific Fundamentals

Market Cap

High in industry

11,243.40 Cr.

PE Ratio (TTM)

High in industry

Dividend Yield

Net Profit TTM

317.4% incr over last year

119.60

Net Profit Growth

317.4% incr over last year

119.60

PEG Ratio

Above industry Median

0.30

ROE

96.1% incr over last year

6.08

Operating Revenue TTM

2,643.78

Operating Revenue Growth

70.4% incr over last year

Book Value

High in industry

12.60

MFI

MFI strongly Overbought

87.82

RSI

RSI Overbought

72.77

EPS (TTM)

4.09

Debt to Equity

0.15

Face Value

Operating Profit Margin Qtr.

18.84

Operating Profit Qtr.

184.25

Net Profit Qtr.

52.11

Operating Revenue Qtr.

919.96

PB Ratio

12.60

Viyash Scientific Financials

*All values are in Rs. Cr

Loading chart...

Indicator	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
Total Revenue	372.49	341.64	34.03	41.07	42.33
Operating Expense	309.80	271.30	36.67	43.11	45.15
Operating Profit	62.69	70.34	-2.64	-2.04	-2.82
Depreciation	31.16	31.20	2.24	2.33	2.30
Interest	2.53	3.56	0.83	1.08	0.99
Tax	12.94	10.69	1.26	1.41	1.68
Net Profit	35.81	-0.08	3.08	3.37	4.23

Viyash Scientific Technicals

Viyash Scientific Ltd. EMA & SMA

₹262.94

1.98 (0.76%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹247.8

Day EMA10 ₹238.9

Day EMA12 ₹236.3

Day EMA20 ₹228.6

Day EMA26 ₹224.7

Day EMA50 ₹216.5

Day EMA100 ₹210.7

Day EMA200 ₹203.2

Viyash Scientific Support and Resistance

Resistance

First Resistance₹266.01

Second Resistance₹271.05

Third Resistance₹280.11

Support

First Support₹251.91

Second Support₹242.85

Third Support₹237.81

Technical Indicators

Day RSI72.77

Day MFI87.82

Day ADX35.44

Day Commodity Channel Index173.20

William-11.27

Day MACD11.63

Day MACD Signal Line8.08

Day ATR12.25

Day ROC1253.56

Day ROC2123.23

Viyash Scientific Shareholding Pattern

Held By	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Promoter	52.6	52.6	52.6	52.3	61.4	61.3
FII	6.1	6	6.2	5.9	3.2	2.9
DII	12	12.9	12.9	12.9	7.3	8
Public	29.1	28.4	28.1	28.7	28	27.7

Viyash Scientific Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	11.14 L	25.41 L	43.84%
Week	22.14 L	70 L	31.63%
1 Month	9.63 L	25.78 L	37.36%
6 Month	5.1 L	11.42 L	44.64%

Viyash Scientific SWOT Analysis

Strengths37

Weakness7

Opportunity6

Threats0

Best results last week in YoY net profit and revenue growth

Benjamin Graham Value Screen

Strong Performer, Getting Expensive (DVM)

Companies with 10% increase in share price over three months, with rising net profit growth

Strong Momentum: Price above short, medium and long term moving averages

Relative Outperformance versus Industry over 1 Month

Rising Net Cash Flow and Cash from Operating activity

Relative Outperformance versus Industry over 1 Year

Companies with high TTM EPS Growth

Growth Stars: Strongest Annual EPS Performers

Stocks whose current price is 20% higher than week low, and more than previous close

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

Stocks gaining versus previous close, open price and RSI

High Momentum Scores (Technical Scores greater than 50)

Good quarterly growth in the recent results

Relative Outperformance versus Industry over 1 Week

Relative Outperformance versus Industry over 1 Month

Overbought by Money Flow Index (MFI)

Effectively using its capital to generate profit - RoCE improving in last 2 years

Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year

Efficient in managing Assets to generate Profits - ROA improving since last 2 year

Growth in Net Profit with increasing Profit Margin (QoQ)

Growth in Quarterly Net Profit with increasing Profit Margin (YoY)

Companies with Low Debt

Increasing profits every quarter for the past 4 quarters

Increasing Revenue every quarter for the past 2 quarters

Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years

Annual Net Profits improving for last 2 years

Companies with Zero Promoter Pledge

Recent Results : Growth in Operating Profit with increase in operating margins (YoY)

Near 52 Week High

Stock gained more than 20% in one month

RSI indicating price strength

Biggest Price Gainers from Open

Stocks near 52 Week High with Significant Volumes

Stocks Outperforming their Industry Price Change in the Quarter

Viyash Scientific Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
08 Sep, 2021	0.5	FINAL	10 Sep, 2021	Equity Share
21 Aug, 2019	0.2	FINAL		Equity Share
20 Nov, 2017	0.2	INTERIM	21 Nov, 2017	Equity Share
16 Sep, 2011	1.5	FINAL		Equity Share
23 Sep, 2010	2	FINAL		Equity Share
02 Sep, 2009	1	FINAL		Equity Share
11 Sep, 2008	1	FINAL		Equity Share
13 Sep, 2007	1	FINAL		Equity Share

Viyash Scientific Stock Comparison

Financials	Corona Remedies Ltd.	Sudeep Pharma Ltd.	Rubicon Research Ltd.	Senores Pharmaceuticals Ltd.	Sanofi Consumer Healthcare India Ltd.	Akums Drugs & Pharmaceuticals Ltd.
Price (₹)	₹1,700	₹696	₹974.90	₹1,153.95	₹4,641	₹532.15
% Change	-0.07%	-0.11%	3.21%	0.03%	0.68%	2.14%
Revenue TTM (₹ Cr)	₹1,403.18	₹642.26	₹1,598.19	₹649.50	₹935	₹4,359.02
Net Profit TTM (₹ Cr)	₹185.12	₹172.89	₹206.20	₹115.38	₹257.90	₹255.19
PE TTM	56.10	45.50	78.30	46.10	41.60	32.80
1 Year Return	59.79	17.55	101.6	127.62	-7.08	-5.98
ROCE	31.54	24.22	34.76	15.60	-	11.40

Similar Stocks

BLUEJET

Blue Jet Healthcare Ltd

₹ 499.00

+3.66%

CONCORDBIO

Concord Biotech Ltd.

₹ 1136.00

+0.36%

AARTIPHARM

Aarti Pharmalabs Ltd.

₹ 694.65

-5.16%

SUPRIYA

Supriya Lifescience Ltd.

₹ 780.00

+1.81%

ALIVUS

Alivus Life Sciences Ltd.

₹ 1088.60

+3.71%

COHANCE

Cohance Lifesciences Ltd.

₹ 433.00

-0.43%

ERIS

Eris Lifesciences Ltd.

₹ 1360.00

+0.48%

SYNGENE

Syngene International Ltd.

₹ 464.00

+0.35%

APLLTD

Alembic Pharmaceuticals Ltd.

₹ 758.95

-0.44%

SPARC

Sun Pharma Advanced Research Company Ltd.

₹ 232.15

-0.36%

STAR

Strides Pharma Science Ltd.

₹ 1165.00

-1.94%

GRANULES

Granules India Ltd.

₹ 757.00

-0.18%

FDC

FDC Ltd.

₹ 401.60

+8.73%

SHILPAMED

Shilpa Medicare Ltd.

₹ 506.00

-1.20%

JUBLPHARMA

Jubilant Pharmova Ltd.

₹ 989.75

-1.74%

CAPLIPOINT

Caplin Point Laboratories Ltd.

₹ 2045.00

-1.58%

MARKSANS

Marksans Pharma Ltd.

₹ 253.90

+15.27%

SANOFI

Sanofi India Ltd.

₹ 3199.00

+0.54%

PGHL

Procter & Gamble Health Ltd.

₹ 5662.50

-1.11%

JSLL

Jeena Sikho Lifecare Ltd.

₹ 638.10

+0.44%

FAQ's on VIYASH

What is the Market Capitalization of Viyash Scientific Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Viyash Scientific Ltd. is approximately ₹ 11243.4 Cr.

What are the PE and PB ratios for Viyash Scientific Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Viyash Scientific Ltd. is 94, and the Price-to-Book (PB) ratio is 12.6.

What is the 52-Week High and Low for Viyash Scientific Ltd.?

Over the past 52 weeks, the highest price reached by Viyash Scientific Ltd. shares was ₹ 268.7, and the lowest price was ₹ 166.

Who are the major shareholders of Viyash Scientific Ltd.?

Significant shareholdings in Viyash Scientific Ltd. typically include entities such as:

Promoter
Public
Mutual Funds
FII
Other Institutions

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of Viyash Scientific Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Viyash Scientific Ltd. is often compared with other major players such as Goldline Pharmaceutical, Sai Parenterals, Speciality Medicines, Accretion Nutraveda, Rekvina Laboratories and Vivimed Labs for analysis and benchmarking.

What is the latest dividend information for Viyash Scientific Ltd.?

Viyash Scientific Ltd. last declared a FINAL dividend of ₹ 0.5 per share for the financial period ending 2021. The record date was set as 2021-09-08, and the payment was/is scheduled around 2021-09-08. For the most current dividend announcements, refer to official company filings.